As a result of an increasing life expectancy, the incidence of colon cancer in the older population is rising. As a consequence oncologists and their older patients commonly face the dilemma of whether or not to give/receive treatment for colon cancer. However, the paucity of large, well conducted prospective trials makes it difficult to provide evidence-based clinical recommendations for these patients. The current evidence supports the safety and efficacy of treatment for colon cancer in fit older patients and demonstrates that treatment outcome can be similar to that of their younger counterparts. However, it should be noted that these data are derived from retrospective studies which are likely to suffer from selection bias. Despite a g...
Colorectal cancer (CRC) is one of the most commonly diagnosed cancers in Europe and worldwide, with ...
BACKGROUND: Although the benefit from adjuvant chemotherapy has been established clearly in patients...
BACKGROUND: Although the benefit from adjuvant chemotherapy has been established clearly in patients...
As a result Of an increasing life expectancy, the incidence of colon cancer in the older population ...
Colorectal cancer (CRC) is one of the commonest malignancies of Western countries, with approximatel...
Colorectal cancer (CRC) is one of the commonest malignancies of Western countries, with approximatel...
Colorectal cancer (CRC) is one of the commonest malignancies of Western countries, with approximatel...
Fifty percent of new diagnoses of colorectal cancer are made in patients aged over 70 years, and 25%...
In a continuously aging population, the burden of colorectal cancer (CRC) is rising among older pati...
AIM: To evaluate changing treatment patterns and survival outcomes of elderly patients (age 70 years...
Fifty percent of new diagnoses of colorectal cancer are made in patients aged over 70 years, and 25%...
Fifty percent of new diagnoses of colorectal cancer are made in patients aged over 70 years, and 25%...
Colorectal cancer (CRC) is one of the most commonly diagnosed cancers in Europe and worldwide, with ...
Colorectal cancer (CRC) is one of the most commonly diagnosed cancers in Europe and worldwide, with ...
Colorectal cancer (CRC) is one of the most commonly diagnosed cancers in Europe and worldwide, with ...
Colorectal cancer (CRC) is one of the most commonly diagnosed cancers in Europe and worldwide, with ...
BACKGROUND: Although the benefit from adjuvant chemotherapy has been established clearly in patients...
BACKGROUND: Although the benefit from adjuvant chemotherapy has been established clearly in patients...
As a result Of an increasing life expectancy, the incidence of colon cancer in the older population ...
Colorectal cancer (CRC) is one of the commonest malignancies of Western countries, with approximatel...
Colorectal cancer (CRC) is one of the commonest malignancies of Western countries, with approximatel...
Colorectal cancer (CRC) is one of the commonest malignancies of Western countries, with approximatel...
Fifty percent of new diagnoses of colorectal cancer are made in patients aged over 70 years, and 25%...
In a continuously aging population, the burden of colorectal cancer (CRC) is rising among older pati...
AIM: To evaluate changing treatment patterns and survival outcomes of elderly patients (age 70 years...
Fifty percent of new diagnoses of colorectal cancer are made in patients aged over 70 years, and 25%...
Fifty percent of new diagnoses of colorectal cancer are made in patients aged over 70 years, and 25%...
Colorectal cancer (CRC) is one of the most commonly diagnosed cancers in Europe and worldwide, with ...
Colorectal cancer (CRC) is one of the most commonly diagnosed cancers in Europe and worldwide, with ...
Colorectal cancer (CRC) is one of the most commonly diagnosed cancers in Europe and worldwide, with ...
Colorectal cancer (CRC) is one of the most commonly diagnosed cancers in Europe and worldwide, with ...
BACKGROUND: Although the benefit from adjuvant chemotherapy has been established clearly in patients...
BACKGROUND: Although the benefit from adjuvant chemotherapy has been established clearly in patients...